Lipitor, Bextra counterfeiting sentence
Executive Summary
Former NuCare Pharmaceuticals CEO Christopher Lamoreaux sentenced to 21 months in federal prison and ordered to pay $115,278.54 to the company for two counts of mail fraud involving counterfeit versions of Pfizer's Lipitor and Bextra, FDA says Nov. 9. Lamoreaux was found guilty of accepting kickbacks for negotiating a contract for NuCare to purchase and repackage counterfeit and diverted drugs from Albers Medical. He was convicted in Kansas City, Mo. federal court in July following an investigation by FDA's Office of Criminal Investigation...